Tarsus Pharmaceuticals COO Neervannan Seshadri sold 4,564 shares at $85 per share. He owned 78,532 shares afterward, and the sale represented about 5.5% of his prior holding. The ownership figures show investors both the transaction’s size and the executive’s reported remaining position.

Key Highlights

  • Neervannan Seshadri’s transaction was dated September 4, 2026, and carried code S.
  • Seshadri was identified as Tarsus Pharmaceuticals’ chief operating officer.
  • The sale represented about 5.5% of Seshadri’s prior shareholding.

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) shares were sold by Chief Operating Officer Neervannan Seshadri at $85 per share, with 4,564 shares changing hands.

September 4 Sale Was Reported Under Code S

The sale was dated September 4, 2026. Its transaction code was S. The record links the transaction to Seshadri’s holdings in Tarsus Pharmaceuticals, Inc. The price was stated on a per-share basis. The transaction involved 4,564 shares of Tarsus Pharmaceuticals. Seshadri’s executive title is identified in the transaction details. The reported sale size was 4,564 shares, while the stated consideration was $85 for each share sold.

Executive Holding After Transaction

Seshadri owned 78,532 shares following the transaction. The shares sold represented about 5.5% of his prior shareholding in Tarsus Pharmaceuticals. The sale represented about 5.5% of Seshadri’s prior shareholding, and 78,532 shares remained reported after the transaction. Transaction code S denotes an open-market or private sale.